ACM
TMDX icon

Aster Capital Management’s Transmedics TMDX Stock Holding History

Aster Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-61
Closed -$4.1K – 1246
2026
Q1 		$4.1K Buy
61
+38
+165% +$4.96K ﹤0.01% 697
2025
Q4 		$2.8K Sell
23
-13
-36% -$1.63K ﹤0.01% 934
2025
Q3 		$4.04K Sell
36
-48
-57% -$5.62K ﹤0.01% 825
2025
Q2 		$11.3K Sell
84
-10,629
-99% -$1.17M ﹤0.01% 776
2025
Q1 		$818K Buy
+10,713
New +$737K 0.15% 201

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Aster Capital Management's TMDX Position: Q2 2026 in Review

Aster Capital Management sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 61 shares — an estimated $4.1K sold.

Aster Capital Management first reported a position in TMDX in Q1 2025 and held it in 5 quarters. The position peaked at $818K in Q1 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Aster Capital Management reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Aster Capital Management sold 61 Transmedics shares in Q2 2026, an estimated $4.1K.
  • Aster Capital Management first reported a position in Transmedics in Q1 2025 and held it in 5 quarters.
  • Aster Capital Management's Transmedics position peaked at $818K in Q1 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.